| Morepen Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500288 |
NSE Symbol : MOREPENLAB |
P/E(TTM) : 40.31 |
|
ISIN Demat : INE083A01026 |
Div & Yield% : 0.48 |
EPS(TTM) : 1.03 |
|
Book Value(₹) : 21.76 |
Market Cap(₹Cr) : 2,275.10 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 369.53 | 391.28 | 381.94 | 403.25 | 383.70 | 385.64 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 369.53 | 391.28 | 381.94 | 403.25 | 383.70 | 385.64 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.75 | 4.09 | 3.14 | 4.87 | 4.63 | 3.07 |
| Total Income | 375.28 | 395.38 | 385.08 | 408.13 | 388.33 | 388.72 |
| Total Expenditure | 341.60 | 372.33 | 351.78 | 371.68 | 340.64 | 337.03 |
| PBIDT | 33.67 | 23.04 | 33.30 | 36.45 | 47.70 | 51.68 |
| Interest | 4.11 | 3.81 | 3.74 | 1.27 | 1.05 | 1.04 |
| PBDT | 29.57 | 19.23 | 29.56 | 35.19 | 46.65 | 50.64 |
| Depreciation | 10.70 | 7.88 | 12.25 | 4.81 | 3.79 | 3.59 |
| Tax | 4.49 | 3.29 | 0.67 | 7.69 | 10.93 | 12.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 4.73 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 14.38 | 8.06 | 11.91 | 22.69 | 31.93 | 35.05 |
| Extra-ordinary Items | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13.54 | 8.06 | 11.91 | 22.69 | 31.93 | 35.05 |
| EPS (Unit Curr.) | 0.26 | 0.15 | 0.20 | 0.41 | 0.60 | 0.69 |
| EPS (Adj) (Unit Curr.) | 0.26 | 0.15 | 0.20 | 0.41 | 0.60 | 0.69 |
| Calculated EPS (Unit Curr.) | 0.26 | 0.15 | 0.22 | 0.41 | 0.58 | 0.69 |
| Calculated EPS (Adj) (Unit Curr.) | 0.26 | 0.15 | 0.22 | 0.41 | 0.58 | 0.69 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.05 | 0.59 | 0.87 | 1.66 | 2.33 | 2.74 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.05 | 0.59 | 0.87 | 1.66 | 2.33 | 2.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 109.58 | 109.58 | 109.58 | 109.58 | 109.58 | 102.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.11 | 5.89 | 8.72 | 9.04 | 12.43 | 13.40 |
| PBDTM(%) | 8.00 | 4.91 | 7.74 | 8.73 | 12.16 | 13.13 |
| PATM(%) | 3.89 | 2.06 | 3.12 | 5.63 | 8.32 | 9.09 |